Interestingly the analysis also showed that IL-17A expression in the tumor and the stromal cells influenced particularly a loss of E-cadherin expression (r = −0.35, p=0.12; Pearson), thereby pointing to a possible collaborative implication of IL-17 and TGF-β to EMT induction (Figure 3(c)). The gene discussed is IL17A; the disease is neoplasm.